Pilot Study for Evaluation of the Need for Protective Ileostomy After Low Anterior Resection Due to Rectal Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether protective ileostomy is required after low anterior resection due to rectal cancer

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Closure of Protective Ileostomy in Rectal Cancer Patients

NCT02997267

Ileostomy - Stoma

COMPLETED NA

Early Ileostomy Closure for Rectal Cancer Patients in North America

NCT05027737

Ileostomy - Stoma Rectal Cancer

RECRUITING NA

Diverting Ileostomy and Anal Functional Outcomes After Anus Preservation Surgery

NCT04776421

Diverting Ileostomy Middle and Low Rectal Cancer Functional Outcome +1 more

UNKNOWN

Feasibility Bowel Dysfunction Program After Low Anterior Resection

NCT04733794

Rectal Cancer Low Anterior Resection

COMPLETED NA

Defunctioning Left-sided Colostomy in Low Anterior Resection for Rectal Cancer

NCT06149741

Rectal Cancer

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Since introduction of total mesorectal excision prognosis and quality of life of patients with rectal cancer of the middle or lower third of the rectum could be improved significantly. There is no valid data about the need of protective ileostomy in these patients. About 10% of the patients develop insufficiency of the anastomosis and might benefit from ileostomy whereas about 90% would not have required protective ileostomy retrospectively. Aim of the study is to show that protective ileostomy is not required if several criteria are fulfilled and early measures in case of clinical impairment are defined. Therefore eligibility criteria include safely performed stapler anastomosis with complete rings and control of impermeability by air insufflation. In the event of clinical impairment in the postoperative course CT scan with KM filling of the rectum to exclude insufficiency of the anastomosis will be performed. In case of insufficiency protective ileostomy will be created. 40 patients will be included.

Comparison: Patients with resectable rectal cancer of the middle or lower third will be intraoperatively randomized to either protective ileostomy or no ileostomy at all.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

protective ileostomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* radical resectable rectal cancer
* low sphincter-preserving resection of carcinomas of the lower and middle third
* preoperative normal continence
* preoperative normal sphincter function
* complete rings after stapler anastomosis
* impermeability of anastomosis for air
* written informed consent